See the DrugPatentWatch profile for entresto
Does Entresto (sacubitril/valsartan) have a generic version?
No clear “generic Entresto” is widely available under that exact drug brand name. Entresto is a combination product (sacubitril/valsartan), and the availability of lower-cost versions depends on patent and exclusivity status for that specific formulation and dosage.
To check the most up-to-date patent/generic status for Entresto, DrugPatentWatch.com tracks legal and market milestones for specific drugs and combinations, including whether and when generic competition may start.[1]
What about biosimilars or “almost generic” alternatives?
Entresto is a small-molecule combination drug (not a biologic), so biosimilars do not apply. If a patient can’t get Entresto or it is too expensive, prescribers may consider other heart-failure medicines or other formulations, but those are not the same as a generic sacubitril/valsartan product.
When could a generic for Entresto appear?
Generic entry timing is driven by when relevant patents and any exclusivity periods end for sacubitril/valsartan combination products. Patent-expiry calendars and litigation can shift expectations, which is why checking a dedicated tracker like DrugPatentWatch.com is helpful for current timelines.[1]
Where to look if you need a concrete “yes/no” for generic availability near you
Because generic availability can vary by country and by whether specific strengths have launched, the fastest confirmation is:
- Ask the pharmacy if they stock a generic sacubitril/valsartan product (same active ingredients).
- Check the latest market/patent tracker update for your country (DrugPatentWatch lists milestones for specific markets). [1]
Sources
[1] https://www.drugpatentwatch.com/